Strategic Capital Raise Funnels $1B to BVI Medical

BVI Medical has completed a $1 billion strategic capital raise in partnership with TPG, a global alternative asset management firm. Besides fully refinancing BVI’s existing debt and adding new equity from both TPG and new investors, the financing strengthens the company’s fiscal position as it looks to accelerate product innovation and expand its global footprint.

“This investment marks a pivotal moment for BVI as we scale our capabilities to meet the rising demand for advanced ophthalmic solutions,” BVI Medical President/CEO Shervin Korangy said. “We are redefining the future of eye surgery and changing the competitive landscape by driving the launch of breakthrough technologies that will empower surgeons worldwide.”

The financing follows a period of accelerated momentum for BVI, during which the company has significantly grown its portfolio of product offerings and built a robust product pipeline. Most recently, BVI expanded its intraocular lens (IOL) manufacturing in Europe to meet growing global demand, introduced new product lines such as SERENITY and SERENITY Toric premium monofocal IOLs, and strengthened its market position through strategic acquisitions.

“TPG is proud to continue our partnership with BVI as it works to scale its global impact in ophthalmic care,” TPG Partner Kendall Garrison stated. “

The company has strengthened its market position while advancing patient care worldwide and this investment will further drive innovation and expansion. We look forward to supporting BVI’s continued success,” TPG Capital Co-Managing Partner John Schilling, M.D., added.

BVI is a diversified global ophthalmic device company delivering high-quality solutions and innovation for advancing eye surgery and improving patients’ vision. With nine decades of developing products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients worldwide. The company supports surgical teams in more than 90 countries worldwide, either directly or through its distribution network.